Enhancing the therapeutic functionality of AAV vectors encoding dystrophin for preclinical DMD gene therapy studies

Project: Research

Project Details

Description

dystrophin, gene therapy
StatusFinished
Effective start/end date1/10/0930/09/10

Funding

  • Muscular Dystrophy Campaign: £63,925.00
  • Muscular Dystrophy Campaign: £67,006.00
  • Muscular Dystrophy Campaign: £67,006.00